Koneksa Solutions
Clinical Endpoints,
The digital and clinical measures that power modern trials captured consistently, wherever your patients are.
High-Quality Data Starts
with the Right Measure
Koneksa brings together validated digital measures, qualified devices, patient-facing assessments, and a patient-centric mobile platform to capture the endpoints that matter across therapeutic areas, trial phases, and data-collection strategies, in over 55 countries.
Whether you need patient-reported outcomes, clinician assessments, wearable sensor data, or novel digital biomarkers, we help you select, configure, and deploy the right measures and deliver clean, analysis-ready data downstream.
Trusted by Leading Pharmaceutical, Biotech and Academic Sponsors
Koneksa has deployed digital measures across multiple therapeutic areas in both interventional and observational trials from decentralized studies to endpoint validation in rare and complex diseases.
Trusted by
and more
Clinical Endpoint Development
Koneksa supports the full lifecycle of digital clinical trials, from portfolio prioritization through final execution, with a focus on validated digital biomarkers and electronic clinical outcome assessments (eCOAs), and on using these measures to strengthen analog trials.
Our cross-functional services close the gap between clinical need and validated digital evidence.
Connected Devices + Measures
A curated catalog of qualified wearables and sensors integrated directly into our platform with device evaluation, regulatory review, and verification and validation built in.
Explore Connected Devices + Measures →
Explore Connected Devices + Measures 
Digital Biomarkers
Novel, validated measures that translate high-frequency sensor and app data into objective, regulatory-ready endpoints grounded in our digital measurement framework.
Explore Digital Biomarkers →
Explore Digital Biomarkers One Catalog, Every Modality
Koneksa supports a broad spectrum of digital and analog measures,
configured to your study’s needs:
Wearable sensor data (tremor, gait ECG, activity)
Mobile cognitive and motor function tasks
Speech and voice biomarkers
Electronic PROs and symptom diaries
In-clinic and remote clinician-assessed video capture
Continuous compliance and adherence monitoring
Proudly driving
40
+
Coached Measures
100
+
Instructed-task Measures
60
+
Device-based Measures
Implementing Digital
Endpoints in CNS Clinical Trials
Sponsors are designing, validating, and operationalizing digital endpoints for modern CNS trials. Digital endpoints, powered by wearable sensors, mobile apps, and advanced analytics, are enabling continuous, objective measurement in real-world settings, improving trial precision and reducing noise. Discover how to move beyond episodic clinic visits with continuous, real-world data, and the regulatory considerations that come with it.
Data that's ready for what comes next
A measure is only as valuable as what you can do with it next.
Koneksa captures every endpoint, patient-reported, clinician-reported, and device-based, through a single, validated pipeline, so your data arrives structured, quality-controlled, and analysis-ready from day one.
No stitching together device vendors and ePRO providers. No reconciling mismatched formats. No months of cleanup before you can see a signal. From the first data point to final analysis, it’s one continuous, auditable system built so the endpoints you capture today become the evidence you need tomorrow.
Powering Measurement Across the Clinical Trial Lifecycle
With a focus on validated digital biomarkers and electronic clinical outcome assessments (eCOAs), Koneksa uses digital measures to enhance analog clinical trials
Proven Performance
Trusted Partnerships
Global Studies Supported
Device + Solutions Integrations
Countries Deployed
Abstracts, Patents + Publications
More from Koneksa
Found 3 Results
Page 1 of 1
Article
The Complete Guide to the Finger Tap Test: What It Measures, How It Is Used, and Why Digital Approaches Are Changing What It Can Reveal
The finger tap test is one of the oldest and most widely used motor assessments in clinical neuroscience. A clinician watches a patient tap as quickly as possible for a... Download
Article
Koneksa at the CNS Summit With Chief Scientific Officer Dr. Elena Izmailova
The digital field has been greatly transformed during the 18 months of the pandemic. The timid pre-pandemic attempts to test and explore digital health technologies (DHT) were swiftly replaced by…
DownloadNews
Koneksa Announces Clinical Pipeline of Validated Digital Biomarkers to Accelerate Life Sciences Research
NEW YORK–(BUSINESS WIRE)–Koneksa, a healthcare technology company developing evidence-based validated digital biomarkers, today announced the launch of its clinical pipeline featuring biomarkers across neuroscience, oncology, respiratory, and other therapeutic areas.... Download
